Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Fresenius Medical Care AG & Co. KGaA
  6. Financials
    FME   DE0005785802

FRESENIUS MEDICAL CARE AG & CO. KGAA

(FME)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 06/17 02:50:04 am
69.47 EUR   -0.73%
06/10FRESENIUS SE  : Buy rating from Goldman Sachs
MD
06/10PRESS RELEASE : SphingoTec Expands Management Team and Appoints new CFO
DJ
06/09DGAP-DD : Fresenius Medical Care AG & Co. KGaA english
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 19 88522 03724 56424 584--
Entreprise Value (EV)2 26 02035 82438 30138 53737 77137 293
P/E ratio 8,84x17,3x17,4x18,3x15,7x14,3x
Yield 2,05%1,75%1,94%1,70%1,89%2,04%
Capitalization / Revenue 1,06x1,17x1,13x1,14x1,09x1,03x
EV / Revenue 1,39x1,90x1,76x1,78x1,67x1,56x
EV / EBITDA 6,15x8,59x7,70x8,82x8,04x7,33x
Price to Book 1,50x1,73x1,80x1,63x1,52x1,45x
Nbr of stocks (in thousands) 306 845298 249292 869292 888--
Reference price (USD) 64,873,983,983,983,983,9
Last update 02/20/201902/20/202002/23/202105/12/202105/12/202105/12/2021
1 EUR in Million
2 USD in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 18 75018 86121 71621 61722 63323 876
EBITDA1 4 2344 1694 9734 3674 6995 089
Operating profit (EBIT)1 3 4422 4502 8022 5522 8973 234
Operating Margin 18,4%13,0%12,9%11,8%12,8%13,5%
Pre-Tax Profit (EBT)1 3 1011 9872 3552 1932 5252 837
Net income1 2 2461 2951 4161 3451 5411 764
Net margin 12,0%6,87%6,52%6,22%6,81%7,39%
EPS2 7,334,274,824,585,355,88
Dividend per Share2 1,331,301,631,431,581,71
Last update 02/20/201902/20/202002/23/202106/15/202106/15/202106/01/2021
1 USD in Million
2 USD
Estimates
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 6 13513 78713 73813 95213 18612 709
Net Cash position1 ------
Leverage (Debt / EBITDA) 1,45x3,31x2,76x3,20x2,81x2,50x
Free Cash Flow1 1 1421 5563 8871 6252 0582 292
ROE (Net Profit / Equities) 18,4%11,5%11,7%9,68%10,5%11,2%
Shareholders' equity1 12 22611 21812 07113 89714 73415 754
ROA (Net Profit / Asset) 7,89%4,06%3,60%3,20%3,87%4,34%
Assets1 28 48031 93339 28542 02239 81840 649
Book Value Per Share2 43,142,646,651,555,357,8
Cash Flow per Share2 7,649,1517,58,8510,311,4
Capex1 1 2011 2141 2601 3341 4171 469
Capex / Sales 6,40%6,44%5,80%6,17%6,26%6,15%
Last update 02/20/201902/20/202002/23/202106/15/202106/15/202105/12/2021
1 USD in Million
2 USD
Estimates
Finances - Leverage
Financial data source
© 2021 S&P Global Market Intelligence
Key data
Capitalization (EUR)
20 496 312 387
Capitalization (USD)
24 837 993 683
Net sales (USD)
21 715 786 720
Number of employees
124 995
Sales / Employee (USD)
173 733
Free-Float
67,8%
Free-Float capitalization (EUR)
13 888 427 508
Free-Float capitalization (USD)
16 830 377 494
Avg. Exchange 20 sessions (USD)
41 544 425
Average Daily Capital Traded
0,20%
EPS & Dividend
Year-on-year evolution of the PER
Help 
The blue ligne is the average P/E ratio (without estimates)
Year-on-year evolution of the Yield
Help 
The blue ligne is the average yield (without estimates)
Change in Enterprise Value/EBITDA
Help 
The blue ligne is the average yield (without estimates)